Manufacturer: Pharmaqo Labs
Pharmaceutical name: Human Chorionic Gonadotropin
Pack: 1 vial (5000iu)
HCG is a hormone that is naturally made by the female placenta during a typical pregnancy. Its function is quite similar to that of luteinizing hormone (LH), known for triggering ovulation. When combined with other medications, HCG is very effective in aiding female patients in achieving pregnancy. Additionally, it can assist male patients facing fertility challenges, often leading to increased testosterone production in such cases.
HCG is frequently prescribed to female patients as part of a treatment plan aimed at inducing: - Ovulation induction in cases of subfertility, often due to impaired follicle maturation or anovulation. - Luteal phase support. - Follicle preparation for puncture in controlled ovarian hyperstimulation protocols, commonly associated with assisted reproductive technologies.
This medication is also commonly prescribed to male patients due to its capability to treat Hypogonadotrophic hypogonadism. Some individuals suffering from idiopathic dysspermias have shown positive responses to treatment with this drug. It is also used for delayed puberty, often linked to inadequate function of the gonadotrophic pituitary glands, and cryptorchidism, except in cases caused by anatomical obstruction.
HCG is a well-known medication that aids both male and female patients with infertility. However, it may also serve other purposes, including the treatment or prevention of various medical conditions not specified here.
For female patients seeking HCG treatment: Infertile women undergoing assisted reproduction, particularly those needing in vitro fertilization, often have tubal abnormalities, which can lead to a higher incidence of ectopic pregnancies after receiving this medication. Therefore, obtaining early ultrasound confirmation at the beginning of a pregnancy to determine whether it is intrauterine is essential. Pregnancies following treatment with this medication are at an increased risk for multiples. Female patients with a history of thrombosis, severe obesity, or thrombophilia should avoid this medication due to a heightened risk of arterial or venous thromboembolic events during or after treatment with HCG. Those treated with this medication may also be more susceptible to pregnancy loss.